Invention Grant
- Patent Title: Peptide vaccine formulations and use thereof for inducing an immune response
-
Application No.: US16079972Application Date: 2017-02-27
-
Publication No.: US11191821B2Publication Date: 2021-12-07
- Inventor: Robert Seder , Geoffrey Lynn
- Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Applicant Address: US MD Bethesda
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US MD Bethesda
- Agency: Klarquist Sparkman, LLP
- International Application: PCT/US2017/019748 WO 20170227
- International Announcement: WO2017/147597 WO 20170831
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/39 ; A61P35/00 ; A61K9/00 ; B82Y5/00

Abstract:
Embodiments of a novel platform for delivering a peptide antigen to a subject to induce an immune response to the peptide antigen are provided. For example, nanoparticle polyplexes are provided that comprise a polymer linked to a peptide conjugate by an electrostatic interaction. The conjugate comprises a peptide antigen linked to a peptide tag through an optional linker. An adjuvant may be included in the nanoparticle polyplex, linked to either the polymer or the conjugate, or admixed with the nanoparticles. The nanoparticle polyplex can be administered to a subject to induce an immune response to the peptide antigen.
Public/Granted literature
- US20190060435A1 PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE Public/Granted day:2019-02-28
Information query